These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15842800)

  • 1. [Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance].
    Li Z; Lin SX; Liang HZ; He JH
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):75-9. PubMed ID: 15842800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
    Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT
    Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
    Li-juan B; Bing L; Zhi L; Yang L; Ying-jie L
    Pathol Res Pract; 2009; 205(12):828-37. PubMed ID: 19625133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
    Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Liang YJ
    Oncol Rep; 2010 Jan; 23(1):141-50. PubMed ID: 19956874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
    Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of macrophage migration inhibitory factor (MIF) on expression of MMP-2,MMP-9,and IL-8 in nasopharyngeal carcinoma cell strains].
    Li Z; Lin SX; Liang YJ; Zong YS
    Ai Zheng; 2004 Feb; 23(2):130-5. PubMed ID: 14960229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
    Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
    Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
    Takeuchi H; Kim J; Fujimoto A; Umetani N; Mori T; Bilchik A; Turner R; Tran A; Kuo C; Hoon DS
    Clin Cancer Res; 2005 Nov; 11(21):7621-8. PubMed ID: 16278380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
    Shi BB; Zhang XH; Wang HJ; Li HZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
    Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR
    Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.
    Horikawa T; Sheen TS; Takeshita H; Sato H; Furukawa M; Yoshizaki T
    Am J Pathol; 2001 Jul; 159(1):27-33. PubMed ID: 11438450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.